###### Strengths and limitations of this study

-   Consecutive patients were approached for recruitment with large numbers obtained.

-   First of its kind in the Australian literature to examine the impact of sex on quality of life following an acute coronary event.

-   Highlights the need for early screening of women for impaired mobility and reduced mood following an acute coronary event.

-   Sex measured rather than gender role (wider social construct), which encourages us to develop more accurate measures for gender for future studies.

-   Socioeconomic status not measured in this study.

Introduction {#s1}
============

Numerous sex differences have been detected in the outcomes of patients with coronary artery disease. Perhaps the most striking is that women who have suffered an acute coronary syndrome (ACS) have higher mortality rates than men.[@R1] In the same vein, women receive significantly less invasive angiography and timely revascularisation, compared with men.[@R1] Women with ACS have more comorbidities, such as diabetes and cerebrovascular disease, and are on average 5--7 years older, than men. However, these differences cannot fully account for the significant sex discrepancies observed in mortality and morbidity following ACS.

This has prompted investigation into social factors such as sex differences in access to care and patient-centred outcomes including symptoms, functional status or health-related quality of life (QoL).[@R3] Among these patient-centred outcome data, women have been observed to report lower health-related QoL, compared with men,[@R6] and also experience greater angina frequency.[@R10] This may be partly explained by biological factors such as coronary anatomy and ejection fraction, but social factors, such as lack of social support,[@R11] play a key role. The current literature also identifies young women (age≤55) at particular risk of increased anginal symptoms and lower QoL post-ACS,[@R12] a subgroup that may benefit from targeted intervention for depressive or anxiety symptoms.

Our prospective large cohort study is the first of its kind to examine differences in QoL post-ACS between the sexes in the Oceania region and aims to fill this gap in the global literature (as most studies have been conducted in North America and Europe). Utilising data from the Australian Victorian Cardiac Outcomes Registry (VCOR), we aimed to examine patient-centred (primary) outcomes and clinical (secondary) outcomes at 30 days post-percutaneous coronary intervention (PCI), with sex as a predictor of these outcomes in mind.

Methods {#s2}
=======

This study was carried out according to the principles of the Strengthening the Reporting of Observational Studies in Epidemiology checklist for cohort studies.[@R13]

Data source and patient population {#s2-1}
----------------------------------

VCOR is an Australian, state-based clinical quality registry designed to monitor the performance and outcome of PCIs in Victoria. VCOR was established in 2012 and is engaged at all 30 Victorian hospitals (13 public and 17 private).[@R14] VCOR prospectively collects baseline demographic, procedural characteristics, in-hospital outcome and 30-day outcome data on all patients who undergo PCI at a given facility through a secure web-based data collection system. All data entry personnel are registered with VCOR and data are entered by trained hospital staff. Data integrity is ensured with regular audit activities conducted by the central registry.[@R15] VCOR is currently funded by the Victorian Department of Health and Human Services. Quality of life (QoL) data are collected at 30 days by means of the EQ-5D-3L questionnaire.[@R16] Patients are contacted over the phone at the time of routine post-PCI 30-day follow-up and are invited to complete the QoL questionnaire. This study was approved by the Monash Health Human Research Ethics Committee with an opt-out consent model.

Patient and public involvement {#s2-2}
------------------------------

This research was performed without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.

Inclusion and exclusion criteria {#s2-3}
--------------------------------

The current study included consecutive patients who received successful or attempted PCI for an ACS from 2013 to 2016 and who were alive at 30 days post-PCI. Those with all EQ-5D-3L questions missing and those who had died before 30 days were excluded from the quality of life analysis. ACS included ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI) and unstable angina (UA). STEMI was defined as elevated biomarkers and new or presumed new ST-segment elevation in two or more contiguous leads. NSTEMI was defined as presence of elevated biomarkers and at least one of either, ECG changes (ST segment depression or T wave abnormalities), or ischaemic symptoms. UA was defined as at least one of either, ECG changes (ST segment depression or T wave abnormalities), or ischaemic symptoms in the absence of elevated biomarkers. Left ventricular ejection fraction (LVEF) was collected during the index admission and 4 weeks post-myocardial infarction (MI) for STEMI patients and within 6 months prior to the index admission and 4 weeks postdischarge for NSTEMI patients. LVEF could be assessed by echocardiogram, Left ventricular angiography, cardiac MRI or nuclear imaging. Normal LVEF was defined as a LVEF \>50%, mild dysfunction as a LVEF 45%--50%, moderate dysfunction as a LVEF 35%--44% and severe dysfunction as LVEF \<35%.

Primary and secondary outcomes {#s2-4}
------------------------------

The primary endpoint was 30-day quality of life assessment using the EQ-5D-3L, an instrument for describing and valuing health states.[@R16] The EQ-5D-3L is composed of five dimensions: mobility, personal care, usual activities, pain/discomfort and anxiety/depression for which the patients can answer with no, some or extreme problems (eg, unable to walk, extreme depression/anxiety symptoms). Patients are also asked to rank on a scale of 1--100, their overall health state at the time of completing the questionnaire.[@R17] Patient responses are used to derive a composite EQ-5D-3L index score, which was adjusted for in our analysis as per Australian values.[@R18] The index score was categorised into 1, 0.5--0.9 and \<0.5. An index score of 1 is consistent with perfect health. Scores of 0.5--0.9 reflect a lower health utility, and scores \<0.5 reflect lowest health utility. In addition to the above, we asked patients to rate their own health state on the EQ-Visual Analogue Scale (VAS) on a scale of 0--100, with higher scores reflecting better self-perception of current health state.

Secondary outcomes were 30-day major adverse cardiovascular events (MACE), major adverse cardiovascular and cerebrovascular events (MACCE) and major bleeding. Thirty-day MACE was defined as new or recurrent MI, stent thrombosis and target vessel revascularisation. Thirty-day MACCE was defined as MACE with the inclusion of stroke. Major bleeding was defined according to the international Bleeding Academic Research Consortium[@R19] and encompassed categories three and five which included bleeding that required blood transfusion, cardiac tamponade, intracranial haemorrhage and/or any fatal bleeding.

Statistical analysis {#s2-5}
--------------------

Patients in the PCI registry who did not complete the EQ-5L-3D questionnaire at routine 30-day follow-up were excluded. Due to the large number of patients in the missing data group, we chose to explore the missing data group's key patient characteristics to determine the possible effect of the distribution of these characteristics on the outcome. Excluded patients (missing data, n=5705, 34.5% of eligible participants) were analysed against those who provided a complete response (n=10 812). The missing data group was also examined by sex to determine if distribution of key characteristics differed by sex.

For the included patients, categorical variables between men and women were analysed using χ^2^ tests or Fisher's exact tests and expressed as numbers and percentages. Normally distributed continuous variables were compared using an independent t-test and expressed as mean and SD, whereas skewed data were compared using Wilcoxon rank-sum and expressed as median and IQR. Univariate ordered logistic regression was used to analyse the EQ-3D-3L questionnaire, whereas univariate and multivariate ordered logistic regression was used to analyse the EQ-3D-3L index category values. For the QoL questions, an OR \>1 refers to a relative change from a good QoL response towards a poorer QoL response, whereas an OR \>1 for the index category refers to a relative change from a low (poor) index response towards a high (good) index response. An OR \<1 for the QoL questions refers to a relative change from a poor QoL response towards a good QoL response, whereas an OR \<1 for the index category refers to a relative change from a high (good) index response towards a low (poor) index response. VAS scores were compared between the sexes as a numerical variable. A p value \<0.05 was considered statistically significant for all analyses.

To determine if QoL differs between male and females, multivariate modelling was undertaken where the association between QoL and sex was adjusted for age, diabetes medication, previous coronary artery bypass grafting (CABG) and/or PCI, cerebrovascular disease (CVD), out-of-hospital cardiac arrest, estimated glomerular filtreation rate (eGFR) category, in-hospital cardiogenic shock, major bleed and ejection fraction (categorised into a binary variable with cut-off at 44), with these potential confounders determined *a priori*. Statistical analyses were performed using Stata V.14.

Results {#s3}
=======

From a total of 17 132 consecutive ACS patients treated with PCI, 615 patients died by 30 days and were excluded. A total of 16 517 patients were followed at 30 days post-PCI with exclusion of 5705 patients (1351 women, 4354 men) who did not complete the QoL assessment. As per above methods, the characteristics of included versus excluded patients are shown in [table 1](#T1){ref-type="table"}. From the patients who completed the 30-day EQ-5D-3L questionnaire, 7440 (58.7%) males and 2223 (57.8%) females fully completed it and another 875 (6.8%) males and 274 (6.9%) females partially it.

###### 

Baseline characteristics for participants who completed 30-day QoL versus participants who did not complete QoL assessment

  Factor                                      QoL completed (n=10 812)   QoL not completed (n=5705)   P value
  ------------------------------------------- -------------------------- ---------------------------- ---------
  Age, median (IQR)                           64.0 (55.0--73.0)          63.0 (54.0--73.0)            \<0.001
  Male                                        8315 (76.9%)               4354 (76.3%)                 0.40
  Body mass index, median (IQR)               28.0 (25.1--31.5)          27.8 (24.8--31.2)            0.003
  Diabetes medication                         2137 (19.8%)               1206 (21.1%)                 0.037
  Previous CABG                               699 (6.5%)                 309 (5.4%)                   0.007
  Previous PCI                                2381 (22.0%)               1060 (18.6%)                 \<0.001
  Cerebrovascular disease history             336 (3.1%)                 206 (3.6%)                   0.084
  Peripheral vascular disease                 342 (3.2%)                 187 (3.3%)                   0.69
  LVEF estimate                                                                                       
   Normal (\>50%)                             4595 (58.5%)               2551 (54.3%)                 \<0.001
   Mild dysfunction (45%--50%)                1992 (25.4%)               1280 (27.3%)                 
   Moderate dysfunction (35%--44%)            946 (12.1%)                632 (13.5%)                  
   Severe dysfunction (\<35%)                 315 (4.0%)                 233 (5.0%)                   
  eGFR, median (IQR)                          91.2 (68.0--117.0)         90.7 (67.2--118.3)           0.45
  Acute coronary syndrome type                                                                        
   Unstable angina                            1715 (15.9%)               800 (14.0%)                  
   NSTEMI                                     5177 (47.9%)               2445 (42.9%)                 
   STEMI                                      3920 (36.3%)               2460 (43.1%)                 
  Cardiogenic shock                           218 (2.0%)                 176 (3.1%)                   \<0.001
  Out-of-hospital cardiac arrest              275 (2.5%)                 176 (3.1%)                   0.042
  Cardiac arrest or preprocedure intubation   471 (4.4%)                 316 (5.5%)                   \<0.001
  Radial access                               5221 (48.4%)               2917 (51.2%)                 \<0.001
  PCI result successful                       10 299 (95.3%)             5410 (94.8%)                 0.23
  In-hospital shock                           115 (1.1%)                 89 (1.6%)                    0.008
  In-hospital myocardial infarction           80 (0.7%)                  35 (0.6%)                    0.38
  New renal impairment                        247 (2.8%)                 162 (3.0%)                   0.32
  Stent thrombosis (definite/probable)        36 (0.3%)                  12 (0.2%)                    0.17
  In-hospital major bleed                     104 (1.0%)                 65 (1.1%)                    0.29
  In-hospital stroke                          28 (0.3%)                  21 (0.4%)                    0.23
  Cardiac rehab referral                      8272 (86.1%)               4503 (89.7%)                 \<0.001

CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.

Baseline and procedural characteristics {#s3-1}
---------------------------------------

The baseline and procedural characteristics and discharge medications are shown in [table 2](#T2){ref-type="table"}. Women were significantly older than men (median 68.0 years, IQR 59.0--78.0 vs 63.0 years (IQR 54.0--71.0)) with more diabetes, history of cerebrovascular disease and renal impairment. Men had a higher rate of previous CABG, previous PCI, impaired LVEF and pre-hospital cardiac arrest. Women had higher rates of UA and NSTEMI, whereas men presented with higher rates of STEMI. Radial vascular access was more commonly used in men than women (p\<0.001). The majority of coronary lesions were successfully treated, with most patients received drug-eluting stents. Women had a higher incidence of right coronary artery and left anterior descending lesions, whereas men had more left main and left circumflex (LCx) lesions.

###### 

Baseline and procedural characteristics according to sex

                                                   Total (n=10 812)   Men (n=8315)         Women (n=2497)       P value
  ------------------------------------------------ ------------------ -------------------- -------------------- ---------
  Age (years), median and IQR                                         63.0 (54.0--71.0)    68.0 (59.0--78.0)    \<0.001
  BMI (kg/m^2^), median and IQR                                       28.1 (25.2--31.2)    27.9 (24.3--32.4)    0.21
  Diabetes, n (%)                                                     1586 (19.1%)         551 (22.1%)          \<0.001
  Previous CABG, n (%)                                                570 (6.9%)           129 (5.2%)           0.003
  Previous PCI, n (%)                                                 1915 (23.0%)         466 (18.7%)          \<0.001
  CVD, n (%)                                                          236 (2.8%)           100 (4.0%)           0.003
  PVD, n (%)                                                          263 (3.2%)           79 (3.2%)            1.00
  LVEF estimate                                                                                                 
   Normal (\>50%)                                                     3468 (57.3%)         1127 (62.8%)         \<0.001
   Mild dysfunction (45%--50%)                                        1589 (26.3%)         403 (22.5%)          
   Moderate dysfunction (35%--44%)                                    746 (12.3%)          200 (11.1%)          
   Severe dysfunction (\<35%)                                         250 (4.1%)           65 (3.6%)            
  eGFR, median (IQR)                                                  95.6 (73.3--120.6)   75.9 (54.5--101.7)   \<0.001
  ACS type                                                                                                      
   Unstable angina                                                    1256 (15.1%)         459 (18.4%)          \<0.001
   NSTEMI                                                             3942 (47.4%)         1235 (49.5%)         
   STEMI                                                              3117 (37.5%)         803 (32.2%)          
  Cardiac arrest and/or pre-procedure intubation                      388 (4.7%)           83 (3.3%)            0.004
  Radial access, n (%)                                                4194 (50.5%)         1027 (41.2%)         \<0.001
  Lesion locations                                                                                              
   Other                                                              305 (3.7%)           67 (2.7%)            0.018
   LAD                                                                3401 (40.9%)         1081 (43.3%)         0.034
   RCA                                                                2918 (35.1%)         935 (37.4%)          0.031
   LCx                                                                2083 (25.1%)         511 (20.5%)          \<0.001
  Drug-eluting stent                                                  6366 (76.6%)         1913 (76.6%)         0.96
  PCI result successful                                               7898 (95.0%)         2401 (96.2%)         0.016

ACS, acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass grafting; CVD, cerebrovascular disease; LAD, left anterior descending; LCx, left circumflex; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease;RCA, right coronary artery; STEMI, ST-elevation myocardial infarction.

Analysis of missing data {#s3-2}
------------------------

Patients with missing QoL data were found to present more acutely with slightly higher rates of STEMI, cardiogenic shock, out-of-hospital cardiac arrest and intubation compared with included patients. They also had higher rates of documented cerebrovascular disease suggesting more widespread vasculopathy at baseline. However, excluded patients were discharged home at the same rate as non-missing data patients, suggesting similar recovery to baseline. They also had higher rates of cardiac rehabilitation referrals, perhaps reflecting recognition of their sicker baseline status. More unwell patients may have had persistent low mood affecting their motivation to participate in follow-up. There were similar proportions of excluded men and women. These results are summarised in [table 1](#T1){ref-type="table"}.

The missing data were then examined by sex. These results are summarised in [online supplementary table 1](#SP1){ref-type="supplementary-material"}. Female patients were older, with a higher incidence of comorbidities including diabetes, previous CABG/PCI, cerebrovascular disease and renal impairment. However, they had higher rates of preserved left ventricular function. They presented with higher rates of NSTEMI and UA and were less likely to have severe presentation with cardiac arrest or require preprocedural intubation. However, they had slightly higher rates of in-hospital shock and were less likely to be referred to cardiac rehabilitation. As the missing females were older and had increased levels of chronic disease compared with the missing males, it is possible that the estimated difference in QoL between males and females may be underestimated.
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30-day quality of life outcomes {#s3-3}
-------------------------------

Thirty-day QoL results are presented in [table 3](#T3){ref-type="table"} and summarised graphically in [figure 1](#F1){ref-type="fig"}. The EQ-5D-3L is divided into no, some or extreme problems. Responses of 'some' and 'extreme' problems were both categorised as 'presence of a problem' when reporting the following summary statistics. To determine if the difference in QoL index score between males and females was consistent at different ages an interaction term of age and sex was included in the multivariate model. There appeared to be a narrowing in the difference in the QoL index score between males and females as age increased; however, this was not significant at the 5% level, p=0.08.

![Proportions of patients with moderate or severe impairment in each EQ-5D-3L domain, according to sex.](bmjopen-2019-034034f01){#F1}

###### 

30-day quality of life (QoL) post-ACS according to sex

  Factor                                     Total (n=10 812)      Men (n=8315)          Women (n=2497)        Odds ratio (95% CI)   P value
  ------------------------------------------ --------------------- --------------------- --------------------- --------------------- ---------
  QoL mobility                                                                                                                       
   No problem                                9455 (87.7%)          7463 (89.9%)          1992 (80.1%)          2.38 (2.06 to 2.75)   \<0.001
   Some problem                              1287 (11.9%)          808 (9.7%)            479 (19.3%)                                 
   Unable to walk around                     44 (0.4%)             27 (0.3%)             17 (0.7%)                                   
  QoL personal care                                                                                                                  
   No problem                                10 245 (95.0%)        7956 (95.9%)          2289 (91.9%)          2.14 (1.73 to 2.66)   \<0.001
   Some problem                              492 (4.6%)            309 (3.7%)            183 (7.3%)                                  
   Unable to wash/dress self                 52 (0.5%)             34 (0.4%)             18 (0.7%)                                   
  QoL usual activity                                                                                                                 
   No problem                                8700 (80.7%)          6889 (83.0%)          1811 (72.8%)          1.84 (1.63 to 2.08)   \<0.001
   Some problem                              1900 (17.6%)          1280 (15.4%)          620 (24.9%)                                 
   Unable to perform usual activities        187 (1.7%)            129 (1.6%)            58 (2.3%)                                   
  QoL pain/discomfort                                                                                                                
   No pain/discomfort                        9305 (86.6%)          7242 (87.6%)          2063 (83.1%)          1.44 (1.24 to 1.67)   \<0.001
   Mod pain/discomfort                       1395 (13.0%)          995 (12.0%)           400 (16.1%)                                 
   Extreme pain/discomfort                   50 (0.5%)             31 (0.4%)             19 (0.8%)                                   
  QoL anxiety/depression                                                                                                             
   No anxiety/depression                     7827 (80.8%)          6132 (82.3%)          1695 (76.0%)          1.49 (1.30 to 1.70)   \<0.001
   Mod anxiety/depression                    1704 (17.6%)          1226 (16.5%)          478 (21.4%)                                 
   Extreme anxiety/depression                150 (1.5%)            94 (1.3%)             56 (2.5%)                                   
  QoL EQ-5D Index Score, median (IQR)        1.0 (0.8 to 1.0)      1.0 (0.8 to 1.0)      1.0 (0.8 to 1.0)                            \<0.001
  QoL own health state today, median (IQR)   80.0 (70.0 to 90.0)   80.0 (70.0 to 90.0)   80.0 (60.0 to 85.0)                         \<0.001

\*Index available in 58.7% of men and 57.8% of women.

ACS, acute coronary syndrome.

In each assessed domain, women were significantly more likely than men to report the presence of a problem. Women reported significantly higher mobility problems compared with men (20.0% vs 10.0%). Radial access was associated with fewer mobility problems (10.6% vs 13.6%, p\<0.001), though this effect was not significant in females. On the EQ-VAS, women's ratings of their own health state were significantly lower than that of men (80.0 for both groups, IQR 60-85 vs 70-90, p\<0.001), despite similar EQ-5D index scores.

Women reported significantly higher personal care issues compared with men (8.6% vs 4.1%,) and a higher inability to perform usual activities (27.2% vs 17.0%). Women were significantly more likely to report moderate pain or discomfort compared with men (16.9% vs 12.4%). They were also more likely to experience moderate or severe symptoms of anxiety and depression, compared with men (23.9% vs 17.8%).

Women had significantly poorer mobility (OR 2.38, 95% CI 2.06 to 2.75, p\<0.001) and higher personal care issues (OR 2.14, 95% CI 2.06 to 2.75, p\<0.001) compared with men, on univariate analysis. Usual activities were affected to a lesser extent but still poorer in women compared with men (OR 1.84, 95% CI 1.63 to 2.08, p\<0.001), as were perceptions of bodily pain (OR 1.44, 95% CI 1.24 to 1.67, p\<0.001) and depression or anxiety (OR 1.49, 95% CI 1.30 to 1.70, p\<0.001), respectively.

The multivariate predictors of quality of life outcomes as assessed by the overall EQ-5D (EuroQol-5Dimensions) index score are shown in [table 4](#T4){ref-type="table"}. Female sex was a significant independent predictor of poorer QoL at 30 days (OR 0.57, 95% CI 0.50 to 0.64, p\<0.001), along with increasing age, presence of diabetes, cerebrovascular disease, left ventricular dysfunction, renal failure, previous CABG or PCI, and in-hospital major bleeding.

###### 

Multivariate predictors of poor QoL at 30 days following ACS, based on EQ-5D index score

                                     n=10 812                  
  ---------------------------------- ---------- -------------- ---------
  Age (for every 10-year increase)   0.94       0.90 to 0.98   0.004
  Female sex                         0.57       0.50 to 0.64   \<0.001
  Diabetes                           0.85       0.75 to 0.96   0.01
  Previous CABG or PCI               0.88       0.78 to 0.99   0.03
  CVD                                0.58       0.43 to 0.78   \<0.001
  Out-of-hospital cardiac arrest     0.47       0.34 to 0.65   \<0.001
  LVEF\>44%                          1.16       1.01 to 1.33   0.04
  Renal failure                      0.53       0.35 to 0.80   0.002
  In-hospital cardiogenic shock      0.73       0.33 to 0.89   0.28
  In-hospital major bleeding         0.54       0.41 to 1.29   0.02

ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; CVD, cerebrovascular disease; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention.

Secondary endpoints {#s3-4}
-------------------

All secondary endpoints are shown in [table 5](#T5){ref-type="table"}, after exclusion of the 615 patients who died before 30 days. Female sex was not associated with increased rates of major bleeding, recurrent myocardial infarction, stroke, major adverse cardiovascular or combined cardiovascular and cerebrovascular events in patients who survived to 30 days.

###### 

Major adverse cardiovascular, cerebrovascular and bleeding events in patients who survived to 30 days, according to sex

  Characteristics   All ACS      STEMI                                       
  ----------------- ------------ ----------- ------ ------------ ----------- ------
  Major bleeding    98 (1.2%)    36 (1.4%)   0.30   61 (2.0%)    22 (2.7%)   0.17
  Recurrent MI      104 (1.3%)   36 (1.4%)   0.48   47 (1.5%)    13 (1.6%)   0.87
  Stroke            28 (0.3%)    10 (0.4%)   0.70   20 (0.6%)    7 (0.9%)    0.47
  MACE              224 (2.7%)   74 (3.0%)   0.49   113 (3.6%)   31 (3.9%)   0.75
  MACCE             251 (3.0%)   84 (3.4%)   0.39   132 (4.2%)   38 (4.7%)   0.56

ACS, acute coronary syndrome; MACCE, major adverse cardiovascular or cerebrovascular event; MACE, major adverse cardiovascular event;MI, myocardial infarction;STEMI, ST-elevation myocardial infarction.

Discussion {#s4}
==========

This study showed that female sex was an independent predictor of poorer QoL at 30 days following an acute coronary event. Women were significantly more likely than men to rate their QoL poorly in all domains of the EQ-5D-3L, including mobility, personal care, usual activities, pain, discomfort, anxiety and depression, and had a poorer self-perception of their health state.

Comorbid conditions {#s4-1}
-------------------

The reasons for poorer overall QoL in women is likely multifactorial---influenced by both biological sex and gender as a social construct. Our results add to previous research demonstrating a reduced QoL in women following ACS in addition to their higher premorbid conditions and older age.[@R3] The presence of a chronic condition such as CAD, cerebrovascular disease or renal failure is known to predict poorer EQ-5D-3L scores following ACS.[@R20] It is possible that women with ACS, due to their older age and medical comorbidities are also more frail. We know that frailty in turn is associated with poorer outcomes after ACS, but is difficult to measure and correct for.[@R23] Further, women had numerically, but not significantly higher rates of major bleeding, recurrent myocardial infarction, stroke, or major cardiovascular and cerebrovascular events, compared with men. However, this was after the exclusion of 30-day deaths, limiting conclusions drawn from these findings.

Physical health factors {#s4-2}
-----------------------

We identified greater issues with mobility, personal care and usual activities in women compared with men at 30 days based on EQ-5D-3L scores. These findings are consistent with previous research and may be explained by an increased prevalence of angina among women.[@R8] They are also likely influenced by other factors, including the observed increased prevalence of diabetes and older age in women with ACS.[@R24] We found that radial access was associated with improved mobility QoL scores, although this effect was not statistically significant in women, potentially due to smaller numbers. In support of this, the literature has shown that women undergoing radial access preferred it for future interventions over those who underwent femoral access.[@R26]

Our study demonstrated that women reported higher levels of pain and discomfort following ACS. Ongoing pain is an issue as this tends to occur in older women, is associated with higher cardiometabolic risk and negatively impacts participation in cardiac rehabilitation.[@R27]

Further, women showed increased symptoms of anxiety and depression following ACS. Higher baseline rates of depression and anxiety are also associated with lower rates of cardiac rehabilitation attendance.[@R28] Mental health diagnoses disproportionately affect younger women post-ACS and are associated with poorer health-related QoL.[@R21] Our results add to the literature in stable CAD, where women have been found to report more depressive symptoms, with similar adverse QoL effects.[@R8]

How can we improve QoL in women? {#s4-3}
--------------------------------

The lower health-related quality of life in women following an ACS invariably leads to loss of productive years and subsequent increased cost to our economy.[@R29] It highlights the need for strategies to improve female patients' QoL. Increasing uptake of cardiac rehabilitation has been shown to have a positive impact on QoL.[@R30] We know that women are significantly less likely to be referred to, and complete cardiac rehab, compared with men.[@R1] Development of female-specific cardiac rehab programmes may be one way to address this, along with approaches that target symptoms of depression and anxiety by providing psychological counselling and support. Women continue to receive less radial access use compared with males, an important finding given that femoral access has been associated with increased complications, particularly major bleeding.[@R31] Ensuring a radial-first approach in women may be another way to combat poorer QoL. As demonstrated by our older study cohort, frailty also needs to be considered in the presentation of female ACS, with an emphasis on a multidisciplinary approach involving not only cardiology but also endocrinology, geriatrics and allied health.

Limitations {#s5}
===========

Our study is limited by the high proportion of missing data. Because of the large number of missing 30-day QoL, we chose to explore the effect of missing rather than employing imputation methods, which all have associated biases. The strength of the data is that important characteristics were available for comparison by missing/non-missing status and the missing status characteristics by sex. The missing analysis suggested that there may be a difference in missing by sex; however, as the missing females were older and had more chronic disease than the missing males, we would expect that the conclusion (females have worse QoL than males) would not change.

Measures of QoL are heterogenous, both within and between instruments with consequent limitations. However, the EQ-5D-3L is widely prevalent (even though cut-offs differ between countries), and is preference-based, also making it suitable in cost-utility analysis.[@R32] The EQ-5D-3L does not capture the specific reasons for limited mobility which could be from a variety of reasons---for example, shortness of breath, which may be cardiac-related or limitations from musculoskeletal disability, which may be related to non-cardiac causes.

Our study examines outcomes by patient sex, but does not explore gender in detail, which is part of the wider social construct comprising norms, roles and relationships in society.[@R33] This encourages us to seek and develop instruments that measure this in an accurate manner. This is important as various aspects of female gender can be associated with poorer outcomes and QoL after an ACS, including restricted access to healthcare and increased anxiety.[@R20] Our registry does not routinely capture socioeconomic data such as marital status and income; this would be useful as the literature has identified that respondents of surveys tend to be female, older and more affluent,[@R4] and that socioeconomic factors independently influence QoL measurements.[@R22] However, its strengths lie in the recruitment of consecutive patents undergoing PCI for ACS with all patients approached for QoL assessment.

Conclusions {#s6}
===========

This is the first Australian study to show a significant sex-related difference in quality of life in a large registry of patients treated with PCI for ACS. The lower health-related qualify of life in women following an ACS is likely to result in loss of productive years with high economic impact. It highlights the ongoing need to improve outcomes in our female cardiac patients.
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